FDA Official Signals New Support for Psychedelic Therapies
FDA Commissioner Martin Makary recently signaled that reviews for psychedelic therapies could soon accelerate.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
FDA Commissioner Martin Makary recently signaled that reviews for psychedelic therapies could soon accelerate.
Read More
A new clinical trial has found that psilocybin may help ease both motor and mood symptoms in people living with Parkinson’s disease.
Read More
Governor DeSantis confirmed he plans to sign a bill that would criminalize psychedelic mushroom spores in Florida.
Read More
A new study from Stanford University has uncovered unexpected results about ketamine’s role in treating depression.
Read More
Researchers found that psychedelics may reduce inflammation in the brain and body by altering gene activity in immune cells.
Read More
The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.
Read More
The VA will explore new treatment options, including psychedelic therapy, according to recent comments from VA Secretary Doug Collins.
Read More
An analysis in Psychology Today suggests patients may find using psychedelics for pain may offer significant benefits.
Read More
Psilocybin use in the United States has surged dramatically since 2019, marking a turning point in both public perception and behavior
Read More
A single dose of a novel psychedelic compound significantly improved memory, according to a new study from the University of Michigan.
Read More